These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 21988169)
1. Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: a novel approach for the treatment of bladder cancer. Bitsika V; Roubelakis MG; Zagoura D; Trohatou O; Makridakis M; Pappa KI; Marini FC; Vlahou A; Anagnou NP Stem Cells Dev; 2012 May; 21(7):1097-111. PubMed ID: 21988169 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure. Zagoura DS; Roubelakis MG; Bitsika V; Trohatou O; Pappa KI; Kapelouzou A; Antsaklis A; Anagnou NP Gut; 2012 Jun; 61(6):894-906. PubMed ID: 21997562 [TBL] [Abstract][Full Text] [Related]
3. Effect of targeted ovarian cancer therapy using amniotic fluid mesenchymal stem cells transfected with enhanced green fluorescent protein-human interleukin-2 in vivo. You Q; Yao Y; Zhang Y; Fu S; Du M; Zhang G Mol Med Rep; 2015 Oct; 12(4):4859-66. PubMed ID: 26179662 [TBL] [Abstract][Full Text] [Related]
4. Combinatorial human progenitor cell transplantation optimizes islet regeneration through secretion of paracrine factors. Bell GI; Meschino MT; Hughes-Large JM; Broughton HC; Xenocostas A; Hess DA Stem Cells Dev; 2012 Jul; 21(11):1863-76. PubMed ID: 22309189 [TBL] [Abstract][Full Text] [Related]
5. Additive effect of bFGF and selenium on expansion and paracrine action of human amniotic fluid-derived mesenchymal stem cells. Park J; Lee JH; Yoon BS; Jun EK; Lee G; Kim IY; You S Stem Cell Res Ther; 2018 Nov; 9(1):293. PubMed ID: 30409167 [TBL] [Abstract][Full Text] [Related]
6. Secretory profiles and wound healing effects of human amniotic fluid-derived mesenchymal stem cells. Yoon BS; Moon JH; Jun EK; Kim J; Maeng I; Kim JS; Lee JH; Baik CS; Kim A; Cho KS; Lee JH; Lee HH; Whang KY; You S Stem Cells Dev; 2010 Jun; 19(6):887-902. PubMed ID: 19686050 [TBL] [Abstract][Full Text] [Related]
7. Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Roubelakis MG; Pappa KI; Bitsika V; Zagoura D; Vlahou A; Papadaki HA; Antsaklis A; Anagnou NP Stem Cells Dev; 2007 Dec; 16(6):931-52. PubMed ID: 18047393 [TBL] [Abstract][Full Text] [Related]
8. Human adipose tissue-derived mesenchymal stem cells inhibit melanoma growth in vitro and in vivo. Ahn JO; Coh YR; Lee HW; Shin IS; Kang SK; Youn HY Anticancer Res; 2015 Jan; 35(1):159-68. PubMed ID: 25550547 [TBL] [Abstract][Full Text] [Related]
9. TRAIL-expressing gingival-derived mesenchymal stem cells inhibit tumorigenesis of tongue squamous cell carcinoma. Xia L; Peng R; Leng W; Jia R; Zeng X; Yang X; Fan M J Dent Res; 2015 Jan; 94(1):219-28. PubMed ID: 25391621 [TBL] [Abstract][Full Text] [Related]
10. Human adipose tissue-derived mesenchymal stem cells inhibit T-cell lymphoma growth in vitro and in vivo. Ahn JO; Chae JS; Coh YR; Jung WS; Lee HW; Shin IS; Kang SK; Youn HY Anticancer Res; 2014 Sep; 34(9):4839-47. PubMed ID: 25202065 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects. Shangguan L; Ti X; Krause U; Hai B; Zhao Y; Yang Z; Liu F Stem Cells; 2012 Dec; 30(12):2810-9. PubMed ID: 23034983 [TBL] [Abstract][Full Text] [Related]
12. Experimental therapy for lung cancer: umbilical cord-derived mesenchymal stem cell-mediated interleukin-24 delivery. Zhang X; Zhang L; Xu W; Qian H; Ye S; Zhu W; Cao H; Yan Y; Li W; Wang M; Wang W; Zhang R Curr Cancer Drug Targets; 2013 Jan; 13(1):92-102. PubMed ID: 23170786 [TBL] [Abstract][Full Text] [Related]
13. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer. Shinagawa K; Kitadai Y; Tanaka M; Sumida T; Onoyama M; Ohnishi M; Ohara E; Higashi Y; Tanaka S; Yasui W; Chayama K Int J Cancer; 2013 Feb; 132(4):813-23. PubMed ID: 22821812 [TBL] [Abstract][Full Text] [Related]
14. Influence of Mesenchymal Stem Cells Conditioned Media on Proliferation of Urinary Tract Cancer Cell Lines and Their Sensitivity to Ciprofloxacin. Maj M; Bajek A; Nalejska E; Porowinska D; Kloskowski T; Gackowska L; Drewa T J Cell Biochem; 2017 Jun; 118(6):1361-1368. PubMed ID: 27873362 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells. Roubelakis MG; Bitsika V; Zagoura D; Trohatou O; Pappa KI; Makridakis M; Antsaklis A; Vlahou A; Anagnou NP J Cell Mol Med; 2011 Sep; 15(9):1896-913. PubMed ID: 21166769 [TBL] [Abstract][Full Text] [Related]
16. Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model. Sartoris S; Mazzocco M; Tinelli M; Martini M; Mosna F; Lisi V; Indraccolo S; Moserle L; Cestari T; Riviera AP; Bifari F; Tridente G; Pizzolo G; Krampera M Stem Cells Dev; 2011 Apr; 20(4):709-19. PubMed ID: 20695752 [TBL] [Abstract][Full Text] [Related]
17. pIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo. Cafforio P; Viggiano L; Mannavola F; Pellè E; Caporusso C; Maiorano E; Felici C; Silvestris F Stem Cell Res Ther; 2017 Sep; 8(1):206. PubMed ID: 28962646 [TBL] [Abstract][Full Text] [Related]
18. Influence of mesenchymal stem cells on metastasis development in mice in vivo. Meleshina AV; Cherkasova EI; Shirmanova MV; Klementieva NV; Kiseleva EV; Snopova LВ; Prodanets NN; Zagaynova EV Stem Cell Res Ther; 2015 Feb; 6(1):15. PubMed ID: 25888992 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic Potential of Secreted Molecules Derived from Human Amniotic Fluid Mesenchymal Stem/Stroma Cells in a Mice Model of Colitis. Legaki E; Roubelakis MG; Theodoropoulos GE; Lazaris A; Kollia A; Karamanolis G; Marinos E; Gazouli M Stem Cell Rev Rep; 2016 Oct; 12(5):604-612. PubMed ID: 27503204 [TBL] [Abstract][Full Text] [Related]
20. Human umbilical cord mesenchymal stem cells as vehicles of CD20-specific TRAIL fusion protein delivery: a double-target therapy against non-Hodgkin's lymphoma. Yan C; Li S; Li Z; Peng H; Yuan X; Jiang L; Zhang Y; Fan D; Hu X; Yang M; Xiong D Mol Pharm; 2013 Jan; 10(1):142-51. PubMed ID: 23121392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]